Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Increasing prevalence of chronic and infectitous diseases
3.4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness
3.4.1.3 Technological Advancements and adoption of home-based point of care devices
3.4.1.4 Increasing healthcare expenditures worldwide

3.4.2 Restraints

3.4.2.1 Stringent regulatory requirements for the approval and commercialization of point of care diagnostic devices
3.4.2.2 Inadequate reimbursement policies for point of care diagnostic devices

3.4.3 Opportunities

3.4.3.1 Developing economies offer lucarative growth opportunities

Chapter: 4 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT

4.1 Overview
4.2 Glucose monitoring kits

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Infectious diseases testing kits

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Hepatitis testing kits

4.3.4.1 Market size and forecast

4.3.5 HIV testing kits

4.3.5.1 Market size and forecast

4.3.6 Respiratory infections testing kits

4.3.6.1 Market size and forecast

4.3.7 Influenza testing kits

4.3.7.1 Market size and forecast

4.3.8 Healthcare-associated infections (HAIs) testing kits

4.3.8.1 Market size and forecast

4.3.9 Sexually-transmitted diseases (STDs) testing kits

4.3.9.1 Market size and forecast

4.3.10 Other infectious disease point of care testing kits

4.3.10.1 Market size and forecast

4.4 Pregnancy and fertility testing kits

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Pregnancy testing kits

4.4.4.1 Market size and forecast

4.4.5 Fertility testing kits

4.4.5.1 Market size and forecast

4.5 Hematology testing kits

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Cardiometabolic monitoring kits

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Cardiac markers test kits

4.6.4.1 Market size and forecast

4.6.5 HbA1c testing kits

4.6.5.1 Market size and forecast

4.6.6 Electrolytes and metabolites testing kits

4.6.6.1 Market size and forecast

4.7 Urinalysis testing devices

4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast

4.8 Coagulation monitoring kits

4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast

4.9 Tumor or cancer markers testing devices

4.9.1 Key market trends
4.9.2 Key growth factors and opportunities
4.9.3 Market size and forecast

4.10 Cholesterol testing strips

4.10.1 Key market trends
4.10.2 Key growth factors and opportunities
4.10.3 Market size and forecast

4.11 Drugs of abuse testing kits

4.11.1 Key market trends
4.11.2 Key growth factors and opportunities
4.11.3 Market size and forecast

4.12 Fecal occult testing kits

4.12.1 Key market trends
4.12.2 Key growth factors and opportunities
4.12.3 Market size and forecast

4.13 Other point of care testing devices

4.13.1 Key market trends
4.13.1 Key growth factors and opportunities
4.13.2 Market size and forecast

Chapter: 5 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast

5.2 Professional diagnostic centers

5.2.1 Market size and forecast
5.2.2 Hospitals/critical care centers

5.2.2.1 Market size and forecast

5.2.3 Outpatient healthcare settings

5.2.3.1 Market size and forecast

5.2.4 Ambulatory care settings

5.2.4.1 Market size and forecast

5.3 Research laboratories

5.3.1 Market size and forecast

5.4 Home

5.4.1 Market size and forecast

5.5 Others

5.5.1 Market size and forecast

Chapter: 6 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION

6.1 Introduction
6.2 Prescription based testing devices

6.2.1 Market size and forecast

6.3 Over-the-counter (OTC) testing devices

6.3.1 Market size and forecast

Chapter: 7 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S. market size and forecast
7.2.5 Canada market size and forecast
7.2.6 Mexico market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany market size and forecast
7.3.5 France market size and forecast
7.3.6 U.K.

7.3.6.1 Market size and forecast

7.3.7 Italy

7.3.7.1 Market size and forecast

7.3.8 Spain

7.3.8.1 Market size and forecast

7.3.9 Rest of Europe

7.3.9.1 Market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan

7.4.4.1 Market size and forecast

7.4.5 China

7.4.5.1 Market size and forecast

7.4.6 India

7.4.6.1 Market size and forecast

7.4.7 Rest of Asia-Pacific

7.4.7.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil

7.5.4.1 Market size and forecast

7.5.5 UAE

7.5.5.1 Market size and forecast

7.5.6 Rest of LAMEA

7.5.6.1 Market size and forecast

Chapter: 8 COMPANY PROFILES

8.1 Abbott Laboratories

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves & developments

8.2 Siemens AG

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves & developments

8.3 F. Hoffmann-La Roche Ltd

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves & developments

8.4 Sinocare Inc.

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Business performance
8.4.4 Key strategic moves & developments

8.5 Johnson & Johnson

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Business performance
8.5.4 Key strategic moves & developments

8.6 Sysmex Corporation

8.6.1 Company overview
8.6.2 Operating product categories
8.6.3 Business performance
8.6.4 Key strategic moves & developments

8.7 Nova Biomedical

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves & developments

8.8 Danaher Corporation

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves & developments

8.9 Becton Dickinson and Company

8.9.1 Company overview
8.9.2 Business performance
8.9.3 Key strategies and development

8.10 bioMrieux SA

8.10.1 Company overview
8.10.2 bioMerieux - COMPANY SNAPSHOT
8.10.3 Operating business segments
8.10.4 Business performance
8.10.5 Key strategic moves & developments

8.11 Bio-Rad Laboratories

8.11.1 Company overview
8.11.2 Operating business segments
8.11.3 Business performance
8.11.4 Key strategic moves & developments

List of Figures

FIG. 1 TOP INVESTMENT POCKETS IN WORLD DEFIBRILLATORS MARKET
FIG. 2 TOP WINNING STRATEGIES PERCENTAGE DISTRIBUTION, 20142016
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP IMPACTING FACTORS WORLD POINT OF CARE DIAGNOSTICS MARKET
FIG. 5 PREVALENCE OF DIABETES MELLITUS (BETWEEN THE AGE GROUP OF 20 79 YEARS) IN MAJOR COUNTRIES, 2010 AND 2030 (MILLIONS)
FIG. 6 APPLICATIONS OF POINT OF CARE DIAGNOSTIC DEVICES
FIG. 7 MEDICAL DEVICE DEVELOPMENT AND APPROVAL PROCEDURE
FIG. 8 WORLD HEPATITIS TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 9 WORLD HIV TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 10 WORLD RESPIRATORY INFECTION TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 11 WORLD INFLUENZA TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 12 WORLD HAIS TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 13 WORLD STDS TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 14 WORLD OTHERS INFECTIOUS DISEASE TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 15 WORLD PREGNANCY TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 16 WORLD FERTILITY TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 17 WORLD CARDIAC MARKERS TEST KITSMARKET, 2014-2022 ($MILLION)
FIG. 18 WORLD HBA1C TESTING KITSMARKET, 2014-2022 ($MILLION)
FIG. 19 WORLD ELECTROLYTES AND METABOLITES TESTING KITS MARKET, 2014-2022 ($MILLION)
FIG. 20 WORLD POINT OF CARE DIAGNOSTIC DEVICES FOR HOSPITALS/CRITICAL CARE CENTERS MARKET, 2014-2022 ($MILLION)
FIG. 21 WORLD POINT OF CARE DIAGNOSTIC DEVICES FOR OUTPATIENT HEALTHCARE SETTINGS MARKET, 2014-2022 ($MILLION)
FIG. 22 WORLD POINT OF CARE DIAGNOSTIC DEVICES FOR AMBULATORY CARE SETTINGS MARKET, 2014-2022 ($MILLION)
FIG. 23 U.S. POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 24 CANADA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 25 MEXICO POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 26 GERMANY POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 27 FRANCE POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 28 U.K. POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 29 ITALY POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 30 SPAIN POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 31 REST OF EUROPE POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 32 JAPAN POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 33 CHINA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 34 INDIA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 35 REST OF ASIA-PACIFIC POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 36 BRAZIL POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 37 UAE POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 38 REST OF LAMEA POINT OF CARE DIAGNOSTICS MARKET, 2014-2022 ($MILLION)
FIG. 39 ABBOTT REVENUE, 2013-2015 ($MILLION)
FIG. 40 ABBOTT REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 41 ABBOTT REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 SIEMENS-REVENUE, 2013-2015 ($MILLION)
FIG. 43 SIEMENS-REVENUE BY INDUSTRIAL BUSINESS, 2015 (%)
FIG. 44 SIEMENS - REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 ROCHE-NET SALES, 2013-2015 ($MILLION)
FIG. 46 ROCHE- REVENUE, BY OPEARTING SEGMENTS 2015 (%)
FIG. 47 ROCHE NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 48 SINOCARE-REVENUE, 2013-2015 ($MILLION)
FIG. 49 JNJ REVENUE, 2013 2015 ($MILLION)
FIG. 50 JNJ- REVENUE, BY SEGMENT, 2015 (%)
FIG. 51 JNJ REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 52 SYSMEX REVENUE, 2013-2015 ($MILLION)
FIG. 53 SYSMEX REVENUEBY BUSINESS SEGMENT (2015)
FIG. 54 SYSMEX REVENUE BY GEOGRAPHY (2015)
FIG. 55 DANAHER:REVENUE, 2013-2015 ($MILLION)
FIG. 56 DANAHER OPERATING SEGMENT REVENUE, 2015 (%)
FIG. 57 DANAHER REVENUE GEOGRAPHY SEGMENT, 2015 (%)
FIG. 58 BD REVENUE, 2013-2015 ($MILLION)
FIG. 59 BD:REVENUE BY SEGMENT (2015)
FIG. 60 BD:REVENUE BY GEOGRAPHY (2015)
FIG. 61 BIOMERIEUX -REVENUE, 2013-2015 ($MILLION)
FIG. 62 BIOMERIEUX, % NET SALES BY GEOGRAPHY (2015)
FIG. 63 BIO-RAD-NET SALES, 2013-2015 ($MILLION)
FIG. 64 BIO-RAD:REVENUEBY OPERATING SEGMENT, 2015 (%)
FIG. 65 BIO RAD REVENUE BY GEOGRAPHY (2015)

List of Tables

TABLE 1 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 2 WORLD GLUCOSE MONITORING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 3 WORLD INFECTIOUS DISEASES TESTING KITSMARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4 WORLD INFECTIOUS DISEASES TESTING KITSMARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 5 WORLD PREGNANCY AND FERTILITY TESTING KITS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6 WORLD PREGNANCY AND FERTILITY TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 WORLD HEMATOLOGY TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 WORLD CARDIOMETABOLIC MONITORING KITS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 9 WORLD CARDIOMETABOLIC MONITORING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10 WORLD URINALYSIS TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 WORLD COAGULATION MONITORING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12 WORLD TUMOR OR CANCER MARKER TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 WORLD CHOLESTEROL TESTING STRIPS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD DRUGS OF ABUSE TESTING KITSMARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15 WORLD FECAL OCCULT TESTING KITS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD OTHER POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022, ($MILLION)
TABLE 18 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR PROFESSIONAL DIAGNOSTIC CENTERS, BY TYPE, 2014-2022 ($MILLION)
TABLE 19 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR PROFESSIONAL DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR HOME END USER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22 WORLD POINT OF CARE DIAGNOSTICS MARKET FOR OTHER END USER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 24 WORLD PRESCRIPTION BASED POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD OTC BASED POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD POINT OF CARE DIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 27 NORTH AMERICA:POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 29 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 30 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 31 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 32 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 33 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 34 EUROPE POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 35 ASIA-PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36 ASIA- PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 37 ASIA- PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 38 ASIA- PACIFIC POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 39 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 41 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 42 LAMEA POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION, 2014-2022 ($MILLION)
TABLE 43 ABBOTTCOMPANY SNAPSHOT
TABLE 44 ABBOTT - OPERATING SEGMENTS
TABLE 45 SIEMENS AG - COMPANY SNAPSHOT
TABLE 46 SIEMENS - OPERATING SEGMENTS
TABLE 47 ROCHECOMPANY SNAPSHOT
TABLE 48 ROCHE - OPERATING SEGMENTS
TABLE 49 SINOCARECOMPANY SNAPSHOT
TABLE 50 SINOCAREOPERATING SEGMENTS
TABLE 51 JNJCOMPANY SNAPSHOT
TABLE 52 JNJ- OPERATING SEGMENTS
TABLE 53 SYSMEX - COMPANY SNAPSHOT
TABLE 54 SYSMEXPRODUCT CATEGORIES
TABLE 55 NOVA BIOMEDICALCOMPANY SNAPSHOT
TABLE 56 NOVA BIOMEDICAL - OPERATING SEGMENTS
TABLE 57 DANAHERCOMPANY SNAPSHOT
TABLE 58 DANAHER- OPERATING SEGMENTS
TABLE 59 BDSNAPSHOT
TABLE 60 BIOMRIEUX - OPERATING SEGMENTS
TABLE 61 BIO-RADCOMPANY SNAPSHOT
TABLE 62 BIO-RAD - OPERATING SEGMENTS